Literature DB >> 10812311

Divalproex sodium to treat concomitant substance abuse and mood disorders.

M Hertzman1.   

Abstract

A retrospective chart review of psychiatric outpatients selected for a combination of alcohol (or other substance abuse) and mood disorders. A subgroup of patients treated with divalproex sodium diminished their substance abuse during the period of treatment for their disorders. This pilot study suggests that prospective, systematic research on divalproex sodium for dual diagnosis is warranted.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10812311     DOI： 10.1016/s0740-5472(99)00080-x

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN： 0740-5472


  3 in total

1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 2.  The bipolar patient with comorbid substance use disorder: recognition and management.

Authors:  Mark J Albanese; Ronald Pies
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 3.  Mood disorders and substance use disorder: a complex comorbidity.

Authors:  Susan B Quello; Kathleen T Brady; Susan C Sonne
Journal:  Sci Pract Perspect       Date:  2005-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.